JNJ

234.6

+0.18%↑

UNH

275.89

-2.31%↓

TMO

570.38

-1.39%↓

ABT

108.46

+0.03%↑

ISRG

474.71

-2.33%↓

JNJ

234.6

+0.18%↑

UNH

275.89

-2.31%↓

TMO

570.38

-1.39%↓

ABT

108.46

+0.03%↑

ISRG

474.71

-2.33%↓

JNJ

234.6

+0.18%↑

UNH

275.89

-2.31%↓

TMO

570.38

-1.39%↓

ABT

108.46

+0.03%↑

ISRG

474.71

-2.33%↓

JNJ

234.6

+0.18%↑

UNH

275.89

-2.31%↓

TMO

570.38

-1.39%↓

ABT

108.46

+0.03%↑

ISRG

474.71

-2.33%↓

JNJ

234.6

+0.18%↑

UNH

275.89

-2.31%↓

TMO

570.38

-1.39%↓

ABT

108.46

+0.03%↑

ISRG

474.71

-2.33%↓

Home・Akciju saraksts・Pulmatrix Inc

Pulmatrix Inc

Atvērts

2.61 2.76

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.54

Max

2.62

Galvenie mērījumi
By Trading Economics
Ienākumi	672K -877K
EPS	-0.24
Peļņas marža	-60,266.667
Darbinieki	2
EBITDA	671K -877K

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-8.4M 9.5M
Iepriekšējā atvēršanas cena	-0.15
Iepriekšējā slēgšanas cena	2.61

Pulmatrix Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 3. febr. 23:11 UTC

Galvenie tirgus virzītāji

Iegādes, apvienošanās, pārņemšana

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

2026. g. 3. febr. 23:50 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 3. febr. 23:50 UTC

Tirgus saruna

Nikkei May Decline After Hitting All-Time High -- Market Talk

2026. g. 3. febr. 23:42 UTC

Tirgus saruna

Gold Edges Lower on Possible Technical Correction -- Market Talk

2026. g. 3. febr. 23:41 UTC

Iegādes, apvienošanās, pārņemšana

KKR Makes AI Play With $10.9B Asia Data-Center Deal

2026. g. 3. febr. 23:38 UTC

Peļņas

AMD Sales Climb on Help From Data-Center Business -- Update

2026. g. 3. febr. 23:29 UTC

Iegādes, apvienošanās, pārņemšana

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

2026. g. 3. febr. 23:27 UTC

Iegādes, apvienošanās, pārņemšana

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

2026. g. 3. febr. 23:25 UTC

Iegādes, apvienošanās, pārņemšana

KKR-Consortium Expects Deal to Close by Early 2H of 2026

2026. g. 3. febr. 23:23 UTC

Iegādes, apvienošanās, pārņemšana

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

2026. g. 3. febr. 23:22 UTC

Iegādes, apvienošanās, pārņemšana

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

2026. g. 3. febr. 23:19 UTC

Tirgus saruna

Australia Gold Miners Tipped to Rally Higher -- Market Talk

2026. g. 3. febr. 23:19 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 3. febr. 22:56 UTC

Galvenie tirgus virzītāji

Iegādes, apvienošanās, pārņemšana

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

2026. g. 3. febr. 22:40 UTC

Peļņas

Amdocs Extends Collaboration With T-Mobile

2026. g. 3. febr. 22:39 UTC

Peļņas

Amdocs 1Q Adj EPS $1.81

2026. g. 3. febr. 22:39 UTC

Peļņas

Amdocs 1Q Rev $1.16B

2026. g. 3. febr. 22:39 UTC

Peļņas

Amdocs 1Q EPS $1.45 >

2026. g. 3. febr. 22:38 UTC

Peļņas

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

2026. g. 3. febr. 22:30 UTC

Iegādes, apvienošanās, pārņemšana

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

2026. g. 3. febr. 22:22 UTC

Iegādes, apvienošanās, pārņemšana

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

2026. g. 3. febr. 22:14 UTC

Peļņas

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

2026. g. 3. febr. 22:13 UTC

Peļņas

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

2026. g. 3. febr. 22:12 UTC

Peļņas

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

2026. g. 3. febr. 22:10 UTC

Peļņas

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

2026. g. 3. febr. 22:10 UTC

Peļņas

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

2026. g. 3. febr. 22:10 UTC

Tirgus saruna

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

2026. g. 3. febr. 22:10 UTC

Peļņas

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

2026. g. 3. febr. 22:09 UTC

Peļņas

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

2026. g. 3. febr. 22:09 UTC

Peļņas

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Salīdzinājums

Cenas izmaiņa

Pulmatrix Inc Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 0 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Pulmatrix Inc — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.